(Q36660538)
Statements
1 reference
A Phase I, open-label, dose escalation study of afatinib, in a 3-week-on/1-week-off schedule in patients with advanced solid tumors (English)
1 reference
John Marshall
1 reference
Jimmy Hwang
1 reference
Ferry A L M Eskens
1 reference
Herman Burger
1 reference
Shakun Malik
1 reference
Martina Uttenreuther-Fischer
1 reference
Peter Stopfer
1 reference
Mahmoud Ould-Kaci
1 reference
Roger B Cohen
1 reference
Nancy L Lewis
1 reference
17 November 2012
1 reference
1 reference
399-408
1 reference
Identifiers
1 reference
1 reference
1 reference